Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR52669
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
All files associated with the entry
Citation: Wake, Noah; Weng, Shuo-Lin; Zheng, Tongyin; Wang, Szu-Huan; Kirilenko, Valentin; Mittal, Jeetain; Fawzi, Nicolas. "Expanding the molecular grammar of polar residues and arginine in FUS prion-like domain phase separation and aggregation." bioRxiv ., .-. (2024).
PubMed: 38405719
Assembly members:
entity_1, polymer, 284 residues, Formula weight is not available
Natural source: Common Name: Human Taxonomy ID: 9606 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Homo sapiens
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: RP1B_FUS_1-284_WT
Entity Sequences (FASTA):
entity_1: MASNDYTQQATQSYGAYPTQ
PGQGYSQQSSQPYGQQSYSG
YSQSTDTSGYGQSSYSSYGQ
SQNTGYGTQSTPQGYGSTGG
YGSSQSSQSSYGQQSSYPGY
GQQPAPSSTSGSYGSSSQSS
SYGQPQSGSYSQQPSYGGQQ
QSYGQQQSYNPPQGYGQQNQ
YNSSSGGGGGGGGGGNYGQD
QSSMSSGGGSGGGYGNQDQS
GGGGSGGYGQQDRGGRGRGG
SGGGGGGGGGGYNRSSGGYE
PRGRGGGRGGRGGMGGSDRG
GFNKFGGPRDQGSRHDSEQD
NSDN
| Data type | Count |
| T1 relaxation values | 208 |
| T2 relaxation values | 208 |
| heteronuclear NOE values | 208 |
| Entity Assembly ID | Entity Name | Entity ID |
|---|---|---|
| 1 | Fused in Sarcoma | 1 |
Entity 1, Fused in Sarcoma 284 residues - Formula weight is not available
| 1 | MET | ALA | SER | ASN | ASP | TYR | THR | GLN | GLN | ALA | ||||
| 2 | THR | GLN | SER | TYR | GLY | ALA | TYR | PRO | THR | GLN | ||||
| 3 | PRO | GLY | GLN | GLY | TYR | SER | GLN | GLN | SER | SER | ||||
| 4 | GLN | PRO | TYR | GLY | GLN | GLN | SER | TYR | SER | GLY | ||||
| 5 | TYR | SER | GLN | SER | THR | ASP | THR | SER | GLY | TYR | ||||
| 6 | GLY | GLN | SER | SER | TYR | SER | SER | TYR | GLY | GLN | ||||
| 7 | SER | GLN | ASN | THR | GLY | TYR | GLY | THR | GLN | SER | ||||
| 8 | THR | PRO | GLN | GLY | TYR | GLY | SER | THR | GLY | GLY | ||||
| 9 | TYR | GLY | SER | SER | GLN | SER | SER | GLN | SER | SER | ||||
| 10 | TYR | GLY | GLN | GLN | SER | SER | TYR | PRO | GLY | TYR | ||||
| 11 | GLY | GLN | GLN | PRO | ALA | PRO | SER | SER | THR | SER | ||||
| 12 | GLY | SER | TYR | GLY | SER | SER | SER | GLN | SER | SER | ||||
| 13 | SER | TYR | GLY | GLN | PRO | GLN | SER | GLY | SER | TYR | ||||
| 14 | SER | GLN | GLN | PRO | SER | TYR | GLY | GLY | GLN | GLN | ||||
| 15 | GLN | SER | TYR | GLY | GLN | GLN | GLN | SER | TYR | ASN | ||||
| 16 | PRO | PRO | GLN | GLY | TYR | GLY | GLN | GLN | ASN | GLN | ||||
| 17 | TYR | ASN | SER | SER | SER | GLY | GLY | GLY | GLY | GLY | ||||
| 18 | GLY | GLY | GLY | GLY | GLY | ASN | TYR | GLY | GLN | ASP | ||||
| 19 | GLN | SER | SER | MET | SER | SER | GLY | GLY | GLY | SER | ||||
| 20 | GLY | GLY | GLY | TYR | GLY | ASN | GLN | ASP | GLN | SER | ||||
| 21 | GLY | GLY | GLY | GLY | SER | GLY | GLY | TYR | GLY | GLN | ||||
| 22 | GLN | ASP | ARG | GLY | GLY | ARG | GLY | ARG | GLY | GLY | ||||
| 23 | SER | GLY | GLY | GLY | GLY | GLY | GLY | GLY | GLY | GLY | ||||
| 24 | GLY | TYR | ASN | ARG | SER | SER | GLY | GLY | TYR | GLU | ||||
| 25 | PRO | ARG | GLY | ARG | GLY | GLY | GLY | ARG | GLY | GLY | ||||
| 26 | ARG | GLY | GLY | MET | GLY | GLY | SER | ASP | ARG | GLY | ||||
| 27 | GLY | PHE | ASN | LYS | PHE | GLY | GLY | PRO | ARG | ASP | ||||
| 28 | GLN | GLY | SER | ARG | HIS | ASP | SER | GLU | GLN | ASP | ||||
| 29 | ASN | SER | ASP | ASN |
sample_1: MES 20 mM; sodium chloride 150 mM; D2O, [U-2H], 5 % v/v; FUS LCRGG1, [U-100% 15N], 10 uM
sample_conditions_1: ionic strength: 150 mM; pH: 5.5; pressure: 1 atm; temperature: 298 K
| Name | Sample | Sample state | Sample conditions |
|---|---|---|---|
| T1/R1 relaxation | sample_1 | isotropic | sample_conditions_1 |
| T2/R2 relaxation | sample_1 | isotropic | sample_conditions_1 |
| 1H-15N heteronoe | sample_1 | isotropic | sample_conditions_1 |
CcpNMR - data analysis
TOPSPIN - collection